The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
about
Results of paclitaxel (day 1 and 8) and carboplatin given on every three weeks in advanced (stage III-IV) non-small cell lung cancerIs a subgroup claim believable? A user's guide to subgroup analyses in the surgical literatureComparison of platinum-based chemotherapy in patients older and younger than 70 years: an analysis of Southwest Oncology Group Trials 9308 and 9509.Lung cancer. 4: chemotherapy for non-small cell lung cancer: the end of the beginning.Chemotherapy versus supportive care in advanced non-small cell lung cancer: improved survival without detriment to quality of life.Chemotherapy in elderly patients with advanced lung cancer. Part II: Treatment of non-small cell lung cancer (NSCLC).First-line erlotinib in patients with advanced non-small-cell lung cancer unsuitable for chemotherapy (TOPICAL): a double-blind, placebo-controlled, phase 3 trialTreatment of stage IV non-small cell lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelinesThe effect of chemotherapy on symptom control and quality of life in patients with advanced non-small cell lung cancer.Gemcitabine with either paclitaxel or vinorelbine vs paclitaxel or gemcitabine alone for elderly or unfit advanced non-small-cell lung cancer patients.Histology as a treatment effect modifier in advanced non-small cell lung cancer: a systematic review of the evidence.Potential influence of being overweight on the development of hepatic dysfunction in Japanese patients with EGFR-mutated non-small cell lung cancer undergoing gefitinib monotherapy: the Okayama Lung Cancer Study Group experience.Management of elderly patients with advanced non-small cell lung cancer: a single-center experience.Chemotherapy for elderly patients with advanced non-small-cell lung cancer.Chemotherapy and quality of life in NSCLC PS 2 patients.Synergistic anti-proliferative and pro-apoptotic activities of 5F and cisplatin in human non-small cell lung cancer NCI-H23 cells.
P2860
Q24799908-E33E1F67-3C85-4FC4-A2C5-746290E2F853Q34527654-ACA99DB8-FA2B-44CA-8263-58F3CEC038C4Q34786733-41772E41-BC7B-4F11-964B-8F40CCF53DF1Q35096015-C4A789A7-1309-4B59-A5E3-3AC822F961E3Q35536245-D8782FA8-C7A8-4E83-9E22-CA8485A6A957Q35980560-567F2A8E-5B3B-43E3-A563-D5C83AE33D83Q36368641-9BA8AD76-527E-490D-8E0A-1FD1D7CF2285Q36412597-B6DC5BE5-8E6E-4E67-9E58-A3E824941F0CQ36448679-A711EA01-47AD-4495-B345-68E9CDF1E57EQ36695414-57F5015C-9932-4192-9934-7C56403C1646Q37908174-6F0D27BE-37FF-411B-96B8-DA4789884074Q40513457-6FBBD9F4-0D9D-47B9-98D1-938E91999930Q44244242-2DA3F794-1623-41E8-94E1-ED72762E22C0Q44346758-5C5A999B-7EF3-45FD-A5B0-0566DBA79DEAQ46093901-CBE343C7-9FA3-4F7D-AE0A-4943AD2703EFQ47103774-0961B27E-58D7-4AE5-B57D-609276D5F7AB
P2860
The benefits of chemotherapy in patient subgroups with unresectable non-small-cell lung cancer.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@en
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@nl
type
label
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@en
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@nl
prefLabel
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@en
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@nl
P356
P1433
P1476
The benefits of chemotherapy i ...... le non-small-cell lung cancer.
@en
P2093
M H Cullen
P304
P356
10.1023/A:1013582618920
P577
2001-12-01T00:00:00Z